Saturday, May 29, 2021
For healthcare practitioners: the first Canadian conference on the current state of scleroderma therapy and research.
Opening Remarks & Welcome
Dr. Shafiq Qaadri (Moderator),
Dr. Shafiq Qaadri goes over the learning objectives and James Gamble, Country Medical Director of Mallincrokdt Pharmaceuticals, welcomes delegates to the 2021 Scleroderma Summit.
State of the Art Therapy for Scleroderma
Dr. Janet Pope
Dr. Janet Pope, Professor of Medicine at Schulich School of Medicine & Dentistry at University of Western Ontario, gives an overview of the state of therapy for Scleroderma in 2021.
Canada's Rare Drug Strategy
Dr. Durhane Wong-Rieger
Dr. Durhane Wong-Rieger, President of the Canadian Organization for Rare Disorders (CORD), discusses the strategy to a national rare diseases framework for Canada.
Access to Treatment: Industry Perspective
Lorraine Boyle, Managing Director of case Market Access Consulting Inc, goes over the industry perspective of rare disorder approaches.
Access to Treatment: Patient Perspective
Maureen Sauvé, Vice President, Advocacy & Public Relations of the Scleroderma Society of Ontario, details the patient perspective and challenges in diagnosing Scleroderma.
Live Panel Discussion
Dr. Shafiq Qaadri
A live panel discussion with Dr. Durhane Wong-Rieger, Dr. Robert Gniadecki, Lorraine Boyle and Maureen Sauvé.
Skin Signs for Systemic Sclerosis
Dr. Robert Gniadecki
Dr. Robert Gniadecki goes over lesions, skin changes, and pitfalls of systemic sclerosis.
Putting Patients in Touch with Support
John Malcolmson talks about Scleroderma Canada's mission to enrich the quality of life for scleroderma patients through advocacy, patient support, education and research.
Live Panel Discussion & Closing Remarks
Dr. Shafiq Qaadri
A live panel discussion with Dr. Durhane Wong-Rieger, Dr. Robert Gniadecki, Lorraine Boyle, Maureen Sauvé and John Malcolmson.